2
Views
2
CrossRef citations to date
0
Altmetric
Symposium Treatment of CHF: AMBULATORY TREATMENT

What to try while congestive heart failure patients are still ambulatory

Pages 66-84 | Published online: 05 Dec 2017

References

  • Cohn JN. Current therapy of the failing heart. Circulation 1988: 78(5 Pt 1): 1099–107
  • Yusuf S, Thorn T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989: 13(5 Suppl):I74–9
  • National Inpatient Profile. Baltimore: HCIA Ine, 1992
  • The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl] Med 1987: 316(23): 1429–35
  • Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325(5):303–10
  • Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with Captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol 1992: 19(4): 842–50
  • Giles TD, Katz R, Sullivan JM, et al. Short-and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus Captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989; 13(6): 1240–7
  • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325(5):293–302
  • Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992; 327(10):669–77
  • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992: 327(10):685–91 [erratum, N Engl J Med 1992: 327(24): 1768]
  • Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314(24): 1547–52
  • Pouleur H, Rousseau MF, Oakley C, et al. Difference in mortality between patients treated with Captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol 1991; 68: 71–4
  • The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with Captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259(4): 539–44
  • DiBianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320(11): 677–83
  • Eichhorn EJ. The paradox of ß-adrenergic blockade for the management of congestive heart failure. Am J Med 1992;92(5): 527–38
  • Engelmeier RS, O'Connell JB, Walsh R, et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 1985; 72(3): 536–46
  • Bristow MR, Gilbert EM, French WJ, et al. Dose response of beta blocker therapy in heart failure: a multicenter, randomized trial of bucindolol versus placebo. (Abstr) Circulation 1990;82 (4 Suppl III): 674
  • Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N EnglJ Med 1982; 307(4): 205–11
  • Waagstein F, Hjalmarson A, Swedeberg K, et al. Beta-blockers in dilated cardiomyopathies: they work. Eur Heart J 1983; 4(Suppl A): 173–8
  • Packer M, Nicod P, Khandheria BR, et al. Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure. (Abstr) J Am Coll Cardiol 1991; 17(2): 274A
  • Miller LW Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results. J Heart Lung Transplant 1991; 10(3): 482–7
  • Miller LW, Merkle EJ, Herrmann V Outpatient dobutamine for end-stage congestive heart failure. Crit Care Med 1990;18(1 Pt 2):S30–3
  • Collins JA, Skidmore MA, Melvin DB, et al. Home intravenous dobutamine therapy in patients awaiting heart transplantation. J Heart Transplant 1990; 9(3 Pt 1): 205–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.